Transgenomic (TBIO) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS: -1.93M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS: -1.93M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q1 EPS of ($0.37), $0.01 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $6.31 million versus the consensus estimate of $6.8 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- Holley Inc. (HLLY) Misses Q3 EPS by 1c ; Offers Guidance
- Kelly Services (KELYA) Misses Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
